Clinical Trial Results:
Phase II study of PHA-739358 administered by a 24-hour IV infusion every 14 days in advanced/metastatic breast, ovarian, colorectal, pancreatic, small cell lung and non small cell lung cancers.
Summary
|
|
EudraCT number |
2006-003772-35 |
Trial protocol |
GB BE IT FR NL DE |
Global completion date |
25 Aug 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
08 Jun 2016
|
First version publication date |
08 Jun 2016
|
Other versions |
|
Summary report(s) |
Phase II study as 24-hour infusion every 14 days in Adv/Met Solid Tumors |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.